Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular Carcinoma
CONCLUSIONS: Hypermethylation of APC promoter appears to be a potential biomarker that could predict patient survival and disease progression outcome in patients with intermediate stage HCC after local ablation treatment.PMID:38527449 | DOI:10.1159/000538455 (Source: Oncology)
Source: Oncology - March 25, 2024 Category: Cancer & Oncology Authors: Chih-Yang Hsiao Chang-Yi Lu Hung-Ju Su Kai-Wen Huang Source Type: research
Potential of using qFibrosis analysis to predict recurrent and survival outcome of patients with hepatocellular carcinoma after hepatic resection
CONCLUSIONS: Combined index calculated with qFibrosis from digital readout of fibrotic status of peri-tumor liver specimen in patients with HCC have prediction values for their disease and survival outcomes. These results demonstrated the potentials to transform histopathological features into quantifiable data that could be used to correlate with clinical outcome.PMID:38527441 | DOI:10.1159/000538456 (Source: Oncology)
Source: Oncology - March 25, 2024 Category: Cancer & Oncology Authors: Chih-Yang Hsiao Yayun Ren Elaine Chng Dean Tai Kai-Wen Huang Source Type: research
Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular Carcinoma
CONCLUSIONS: Hypermethylation of APC promoter appears to be a potential biomarker that could predict patient survival and disease progression outcome in patients with intermediate stage HCC after local ablation treatment.PMID:38527449 | DOI:10.1159/000538455 (Source: Oncology)
Source: Oncology - March 25, 2024 Category: Cancer & Oncology Authors: Chih-Yang Hsiao Chang-Yi Lu Hung-Ju Su Kai-Wen Huang Source Type: research
Potential of using qFibrosis analysis to predict recurrent and survival outcome of patients with hepatocellular carcinoma after hepatic resection
CONCLUSIONS: Combined index calculated with qFibrosis from digital readout of fibrotic status of peri-tumor liver specimen in patients with HCC have prediction values for their disease and survival outcomes. These results demonstrated the potentials to transform histopathological features into quantifiable data that could be used to correlate with clinical outcome.PMID:38527441 | DOI:10.1159/000538456 (Source: Oncology)
Source: Oncology - March 25, 2024 Category: Cancer & Oncology Authors: Chih-Yang Hsiao Yayun Ren Elaine Chng Dean Tai Kai-Wen Huang Source Type: research
Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular Carcinoma
CONCLUSIONS: Hypermethylation of APC promoter appears to be a potential biomarker that could predict patient survival and disease progression outcome in patients with intermediate stage HCC after local ablation treatment.PMID:38527449 | DOI:10.1159/000538455 (Source: Oncology)
Source: Oncology - March 25, 2024 Category: Cancer & Oncology Authors: Chih-Yang Hsiao Chang-Yi Lu Hung-Ju Su Kai-Wen Huang Source Type: research
Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution Experience
CONCLUSION: Incorporating radiotherapy into multimodal treatment has led to favorable outcomes in patients with ependymoma, and the extent of resection is a prognostic factor for the local control of intracranial ependymoma.PMID:38471461 | DOI:10.1159/000538321 (Source: Oncology)
Source: Oncology - March 12, 2024 Category: Cancer & Oncology Authors: Tiffany Ting-Fong Liu Jason Chia-Hsien Cheng Yu-Hsuan Chen Feng-Ming Hsu Keng-Hsueh Lan Chao-Yuan Huang Chun-Wei Wang Sung-Hsin Kuo Source Type: research
Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution Experience
CONCLUSION: Incorporating radiotherapy into multimodal treatment has led to favorable outcomes in patients with ependymoma, and the extent of resection is a prognostic factor for the local control of intracranial ependymoma.PMID:38471461 | DOI:10.1159/000538321 (Source: Oncology)
Source: Oncology - March 12, 2024 Category: Cancer & Oncology Authors: Tiffany Ting-Fong Liu Jason Chia-Hsien Cheng Yu-Hsuan Chen Feng-Ming Hsu Keng-Hsueh Lan Chao-Yuan Huang Chun-Wei Wang Sung-Hsin Kuo Source Type: research
Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution Experience
CONCLUSION: Incorporating radiotherapy into multimodal treatment has led to favorable outcomes in patients with ependymoma, and the extent of resection is a prognostic factor for the local control of intracranial ependymoma.PMID:38471461 | DOI:10.1159/000538321 (Source: Oncology)
Source: Oncology - March 12, 2024 Category: Cancer & Oncology Authors: Tiffany Ting-Fong Liu Jason Chia-Hsien Cheng Yu-Hsuan Chen Feng-Ming Hsu Keng-Hsueh Lan Chao-Yuan Huang Chun-Wei Wang Sung-Hsin Kuo Source Type: research
Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution Experience
CONCLUSION: Incorporating radiotherapy into multimodal treatment has led to favorable outcomes in patients with ependymoma, and the extent of resection is a prognostic factor for the local control of intracranial ependymoma.PMID:38471461 | DOI:10.1159/000538321 (Source: Oncology)
Source: Oncology - March 12, 2024 Category: Cancer & Oncology Authors: Tiffany Ting-Fong Liu Jason Chia-Hsien Cheng Yu-Hsuan Chen Feng-Ming Hsu Keng-Hsueh Lan Chao-Yuan Huang Chun-Wei Wang Sung-Hsin Kuo Source Type: research
Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution Experience
CONCLUSION: Incorporating radiotherapy into multimodal treatment has led to favorable outcomes in patients with ependymoma, and the extent of resection is a prognostic factor for the local control of intracranial ependymoma.PMID:38471461 | DOI:10.1159/000538321 (Source: Oncology)
Source: Oncology - March 12, 2024 Category: Cancer & Oncology Authors: Tiffany Ting-Fong Liu Jason Chia-Hsien Cheng Yu-Hsuan Chen Feng-Ming Hsu Keng-Hsueh Lan Chao-Yuan Huang Chun-Wei Wang Sung-Hsin Kuo Source Type: research
Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution Experience
CONCLUSION: Incorporating radiotherapy into multimodal treatment has led to favorable outcomes in patients with ependymoma, and the extent of resection is a prognostic factor for the local control of intracranial ependymoma.PMID:38471461 | DOI:10.1159/000538321 (Source: Oncology)
Source: Oncology - March 12, 2024 Category: Cancer & Oncology Authors: Tiffany Ting-Fong Liu Jason Chia-Hsien Cheng Yu-Hsuan Chen Feng-Ming Hsu Keng-Hsueh Lan Chao-Yuan Huang Chun-Wei Wang Sung-Hsin Kuo Source Type: research
Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution Experience
CONCLUSION: Incorporating radiotherapy into multimodal treatment has led to favorable outcomes in patients with ependymoma, and the extent of resection is a prognostic factor for the local control of intracranial ependymoma.PMID:38471461 | DOI:10.1159/000538321 (Source: Oncology)
Source: Oncology - March 12, 2024 Category: Cancer & Oncology Authors: Tiffany Ting-Fong Liu Jason Chia-Hsien Cheng Yu-Hsuan Chen Feng-Ming Hsu Keng-Hsueh Lan Chao-Yuan Huang Chun-Wei Wang Sung-Hsin Kuo Source Type: research
Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution Experience
CONCLUSION: Incorporating radiotherapy into multimodal treatment has led to favorable outcomes in patients with ependymoma, and the extent of resection is a prognostic factor for the local control of intracranial ependymoma.PMID:38471461 | DOI:10.1159/000538321 (Source: Oncology)
Source: Oncology - March 12, 2024 Category: Cancer & Oncology Authors: Tiffany Ting-Fong Liu Jason Chia-Hsien Cheng Yu-Hsuan Chen Feng-Ming Hsu Keng-Hsueh Lan Chao-Yuan Huang Chun-Wei Wang Sung-Hsin Kuo Source Type: research
Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution Experience
CONCLUSION: Incorporating radiotherapy into multimodal treatment has led to favorable outcomes in patients with ependymoma, and the extent of resection is a prognostic factor for the local control of intracranial ependymoma.PMID:38471461 | DOI:10.1159/000538321 (Source: Oncology)
Source: Oncology - March 12, 2024 Category: Cancer & Oncology Authors: Tiffany Ting-Fong Liu Jason Chia-Hsien Cheng Yu-Hsuan Chen Feng-Ming Hsu Keng-Hsueh Lan Chao-Yuan Huang Chun-Wei Wang Sung-Hsin Kuo Source Type: research
Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution Experience
CONCLUSION: Incorporating radiotherapy into multimodal treatment has led to favorable outcomes in patients with ependymoma, and the extent of resection is a prognostic factor for the local control of intracranial ependymoma.PMID:38471461 | DOI:10.1159/000538321 (Source: Oncology)
Source: Oncology - March 12, 2024 Category: Cancer & Oncology Authors: Tiffany Ting-Fong Liu Jason Chia-Hsien Cheng Yu-Hsuan Chen Feng-Ming Hsu Keng-Hsueh Lan Chao-Yuan Huang Chun-Wei Wang Sung-Hsin Kuo Source Type: research
